|
AU2011343599A1
|
|
Steroid tetrol solid state forms
|
|
AU2011343548A1
|
|
Steroid tetrol solid state forms-2
|
|
EP2667876A2
|
|
Methods and compounds for preparing 3alpha-oxygen substituted steroids
|
|
EP2506855A1
|
|
Anticancer compounds and screening method
|
|
US2010222425A1
|
|
15-OXA-steroid compounds
|
|
US2011009372A1
|
|
Compounds and compositions
|
|
CA2724130A1
|
|
Methods for preparing 17-alkynyl-7-hydroxy steroids and related compounds
|
|
KR20100132539A
|
|
Solid state forms of a pharmaceutical
|
|
CA2712005A1
|
|
Pharmaceutical solid state forms
|
|
EP2185112A2
|
|
Stabilized therapeutic compositions and formulations
|
|
US2007077201A1
|
|
Stem cell expansion and uses
|
|
AU2005330504A1
|
|
Steroid analogs and characterization and treatment methods
|
|
AU2005211675A1
|
|
Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone
|
|
AU2002244247B2
|
|
Use of certain steroids for treatment of blood cell deficiencies
|
|
EP1422234A2
|
|
Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone
|
